Labcyte Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 200

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Labcyte General Information

Description

Developer of an acoustic droplet ejection (ADE) technology designed to enhance personalized medicine programs. The company's technology uses acoustic energy to transfer precise amounts of fluids without touching them, which can improve data quality and reliability and focuses on ultrasonic acoustic energy into a fluid sample to eject droplets of liquid from open wells, enabling healthcare industry to streamline DNA/RNA diagnostic testing, optimize drug discovery pipelines and accelerate life science research.

Contact Information

Website
www.labcyte.com
Formerly Known As
Picoliter
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 170 Rose Orchard Way
  • San Jose, CA 95134
  • United States
Primary Industry
Other Devices and Supplies
Acquirer
Vertical(s)
Corporate Office
  • 170 Rose Orchard Way
  • San Jose, CA 95134
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Labcyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 30-Jan-2019 Completed Generating Revenue
10. Later Stage VC 01-Nov-2017 Completed Generating Revenue
9. Later Stage VC (Series E) 03-Jan-2017 Completed Generating Revenue
8. Secondary Transaction - Private Completed Generating Revenue
7. Debt - General 06-May-2015 Completed Generating Revenue
6. Later Stage VC (Series D) 19-Sep-2013 Completed Generating Revenue
5. Grant 09-Nov-2011 Completed Generating Revenue
4. Mezzanine 12-Nov-2009 Completed Generating Revenue
3. Later Stage VC (Series C) 13-Mar-2008 $24.8M $52.6M Completed Generating Revenue
2. Early Stage VC (Series B) 09-Jul-2002 $22.5M $27.8M Completed Startup
To view Labcyte’s complete valuation and funding history, request access »

Labcyte Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 28,137,025 $0.010000 $0.06 $0.8 $0.8 1x $0.8 19.56%
Series A 10,277,815 $0.010000 $0.04 $0.54 $0.54 1x $0.54 7.14%
To view Labcyte’s complete cap table history, request access »

Labcyte Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an acoustic droplet ejection (ADE) technology designed to enhance personalized medicine programs. The compa
Other Devices and Supplies
San Jose, CA
200 As of 2019

Hamburg, Germany
 

Tuttlingen, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Labcyte Competitors (14)

One of Labcyte’s 14 competitors is Eppendorf, a Corporation company based in Hamburg, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eppendorf Corporation Hamburg, Germany
Hettich Private Equity-Backed Tuttlingen, Germany
Autogen Corporation Holliston, MA
Eppendorf India Corporation Chennai, India
Illumina Formerly VC-backed San Diego, CA
You’re viewing 5 of 14 competitors. Get the full list »

Labcyte Patents

Labcyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026117585-A1 Container plate alignment for acoustic droplet ejection Pending 26-Nov-2024
WO-2026084901-A1 Acoustic transducer refocusing for uninterrupted acoustic drop ejection Pending 14-Oct-2024
US-20250166984-A1 Frequency decoupling in dynamic fluidic analysis and acoustic droplet ejection Pending 31-Oct-2023
EP-4709532-A1 Acoustic transducer array assembly Pending 12-May-2023
WO-2024238394-A1 Acoustic transducer array assembly Inactive 12-May-2023 B06B1/06
To view Labcyte’s complete patent history, request access »

Labcyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Labcyte Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Alloy Ventures Venture Capital Minority
Cross Atlantic Partners PE/Buyout Minority
DBL Partners Venture Capital Minority
Delphi Ventures (California) Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Labcyte Acquisitions (3)

Labcyte’s most recent deal was a Merger/Acquisition with EDC Biosystems. The deal was made on 30-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EDC Biosystems 30-Sep-2020 Merger/Acquisition Discovery Tools (Healthcare)
Allegro Technologies 27-Jan-2008 Merger/Acquisition Medical Supplies
Picoliter 04-Nov-2003 Merger of Equals Biotechnology
To view Labcyte’s complete acquisitions history, request access »

Labcyte FAQs

  • When was Labcyte founded?

    Labcyte was founded in 2000.

  • Where is Labcyte headquartered?

    Labcyte is headquartered in San Jose, CA.

  • What is the size of Labcyte?

    Labcyte has 200 total employees.

  • What industry is Labcyte in?

    Labcyte’s primary industry is Other Devices and Supplies.

  • Is Labcyte a private or public company?

    Labcyte is a Private company.

  • What is Labcyte’s current revenue?

    The current revenue for Labcyte is .

  • How much funding has Labcyte raised over time?

    Labcyte has raised $92M.

  • Who are Labcyte’s investors?

    Abingworth, Alloy Ventures, Cross Atlantic Partners, DBL Partners, and Delphi Ventures (California) are 5 of 14 investors who have invested in Labcyte.

  • Who are Labcyte’s competitors?

    Eppendorf, Hettich, Autogen, Eppendorf India, and Illumina are some of the 14 competitors of Labcyte.

  • When was Labcyte acquired?

    Labcyte was acquired on 30-Jan-2019.

  • Who acquired Labcyte?

    Labcyte was acquired by Beckman Coulter.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process